GlassScriptPhysician profile
Prabhpreet Singh
NPI 1093026833
$36,510.99
in general payments reported to CMS, 2019-2025
12 companies · $1,895 in 2025
The $1,895 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $4,426 · 2021: $742 · 2022: $221 · 2023: $4,326 · 2024: $667 · 2025: $1,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,110 · Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,110.22 |
| Food and Beverage | $1,777.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,781.95 | 2019-2025 | Farapulse, Watchman Flx |
| Medtronic Vascular, INC. | $11,469.44 | 2019 | |
| Abbott Laboratories | $7,798.44 | 2019-2025 | Aveir, Amplatzer Amulet, Ensite |
| Medical Device Business Services, INC. | $1,775.40 | 2019-2021 | |
| Biotronik INC. | $1,176.91 | 2019-2021 | |
| Medtronic, INC. | $499.80 | 2021-2025 | Micra |
| Biosense Webster, INC. | $460.52 | 2021-2025 | Carto 3 |
| Nobel Biocare USA | $257.66 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $231.53 | 2019 | |
| Irhythm Technologies, INC. | $31.18 | 2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $15.30 | 2019 | |
| Gilead Sciences, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhpreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.